Pharmaceutical Executives Testimony on Drug Pricing, Day 1
Bristol-Myers Squibb CEO Dr. Giovanni Caforio, Teva CEO Kare Schultz and former Celgene CEO Mark Alles testified on prescription drug pricin… read more
Bristol-Myers Squibb CEO Dr. Giovanni Caforio, Teva CEO Kare Schultz and former Celgene CEO Mark Alles testified on prescription drug pricing before the House Oversight and Reform Committee. Members pressed the pharmaceutical executives on why the retail prices of their drugs frequently increase and at a rate that far exceeds inflation. The drug makers defended the price hikes as the cost of doing research and development and talked about price-reduction programs that their companies offer. This was the first day of a two-part hearing with pharmaceutical executives. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
More PeopleHosting Organization
Related Video
-
Pharmaceutical Executives Testimony on Drug Pricing, Day 2
Amgen CEO Robert Bradway, Novartis U.S. Country President Thomas Kendris, and Mallinckrodt Pharmaceuticals CEO Mark Trud…
-
Health Issues for Veterans Deployed to Karshi-Khanabad Airbase
The House Oversight and Reform Subcommittee on National Security held a hearing on the health concerns surrounding veter…
-
Representative Peter Welch on the Impeachment Inquiry
Representative Peter Welch (D-VT) talked about the House impeachment inquiry of President Trump and prescription drug pr…
-
House Oversight and Reform Committee Hearing on Prescription Drug Prices
The House Oversight and Reform Committee held a hearing on prescription drug prices and their impact on patients. Four p…